Barely Significant
← all excerpts

Efficacy of adjuvant therapy regimens administered during the perioperative period in resectable non-small cell lung cancer.

Cancer Immunol Immunother · 2025 · PMC12401851 · PMID 40888897

Europe PMCDOI
1
hedged sentence
0.2856
closest p · 5.7× alpha
0.2856
boldest claim

The sentences

showed a trendP = 0.2856not close (p > 0.1)
Among patients who did not achieve pCR following NCIT, the IT group showed a trend toward improved OS compared with the no-treatment group (HR: 3.08, 95% CI 1.04–9.13, Adjusted P = 0.2856; Fig. 5 b).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.